COVID‐19 and psoriasis: Is it time to limit treatment with immunosuppressants? A call for action

Citations Over TimeTop 10% of 2020 papers

Abstract

Dermatologic TherapyVolume 33, Issue 4 e13298 Letter to the Editor COVID-19 and psoriasis: Is it time to limit treatment with immunosuppressants? A call for action Claudio Conforti, Claudio Conforti orcid.org/0000-0001-5126-8873 Dermatology Clinic, Maggiore Hospital, University of Trieste, Trieste, ItalySearch for more papers by this authorRoberta Giuffrida, Corresponding Author Roberta Giuffrida [email protected] orcid.org/0000-0002-5492-3033 Department of Clinical and Experimental Medicine, Dermatology, University of Messina, Messina, Italy Correspondence Roberta Giuffrida, Department of Clinical and Experimental Medicine, Dermatology, University of Messina, Messina, Italy. Email: [email protected]Search for more papers by this authorCaterina Dianzani, Caterina Dianzani Department of Plastic, Reconstructive and Cosmetic Surgery, Dermatology Section, Campus Bio-Medico University Hospital, Rome, ItalySearch for more papers by this authorNicola Di Meo, Nicola Di Meo Dermatology Clinic, Maggiore Hospital, University of Trieste, Trieste, ItalySearch for more papers by this authorIris Zalaudek, Iris Zalaudek Dermatology Clinic, Maggiore Hospital, University of Trieste, Trieste, ItalySearch for more papers by this author Claudio Conforti, Claudio Conforti orcid.org/0000-0001-5126-8873 Dermatology Clinic, Maggiore Hospital, University of Trieste, Trieste, ItalySearch for more papers by this authorRoberta Giuffrida, Corresponding Author Roberta Giuffrida [email protected] orcid.org/0000-0002-5492-3033 Department of Clinical and Experimental Medicine, Dermatology, University of Messina, Messina, Italy Correspondence Roberta Giuffrida, Department of Clinical and Experimental Medicine, Dermatology, University of Messina, Messina, Italy. Email: [email protected]Search for more papers by this authorCaterina Dianzani, Caterina Dianzani Department of Plastic, Reconstructive and Cosmetic Surgery, Dermatology Section, Campus Bio-Medico University Hospital, Rome, ItalySearch for more papers by this authorNicola Di Meo, Nicola Di Meo Dermatology Clinic, Maggiore Hospital, University of Trieste, Trieste, ItalySearch for more papers by this authorIris Zalaudek, Iris Zalaudek Dermatology Clinic, Maggiore Hospital, University of Trieste, Trieste, ItalySearch for more papers by this author First published: 11 March 2020 https://doi.org/10.1111/dth.13298Citations: 47Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL No abstract is available for this article.Citing Literature Volume33, Issue4July/August 2020e13298 This article also appears in:Dermatologic Therapy COVID-19 Articles RelatedInformation

Related Papers

• → A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS(2020)522 cited
• → Emerging 2019 Novel Coronavirus (2019-nCoV) Pneumonia(2020)216 cited
• → Serologic testing of coronaviruses from MERS-CoV to SARS-CoV-2: Learning from the past and anticipating the future(2020)12 cited
• → Vaccine effectiveness of ChAdOx1 nCoV-19 against COVID-19 in a socially vulnerable community in Rio de Janeiro, Brazil: author's response(2022)5 cited